carlisle medical
Refill Requests shipment tracking contact carlisle medical
Knowledge Center
Industrial related news
DEA Finalizes Rule to Schedule Tramadol
Released: 07/02/2014
By: Carl Richie, Pharmacy Manager

On July 2, 2014, the Drug Enforcement Administration (DEA) published in the Federal Register the final rule placing tramadol into Schedule IV of the Controlled Substances Act. This rule will become effective on August 18, 2014. At this time, all regulatory requirements applicable to Schedule IV controlled substances will apply to tramadol.

Tramadol is used to treat moderate to severely moderate pain. Tramadol is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.

<<Back
 
Company News
Generic Releases
Industry Related News
Industry Related Links
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2018 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer